Q3028 HCPCS code: Injection, interferon beta-1a, 1 mcg for subcutaneous use
Q3028 is the HCPCS Level II code for injection, interferon beta-1a, 1 mcg for subcutaneous use. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | I — Not payable by Medicare |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | O1E — Other drugs |
| Added | 2014-01-01 |
| Last action effective | 2014-01-01 |
What changed for Q3028
- 2014-01-01: Q3028 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q3028?
Q3028 is the HCPCS Level II code for injection, interferon beta-1a, 1 mcg for subcutaneous use. Short descriptor: "Inj beta interferon sq 1 mcg".
Does Medicare cover Q3028?
Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.
Related Q30 codes
- Q3001 — Radioelements for brachytherapy, any type, each
- Q3014 — Telehealth originating site facility fee
- Q3027 — Injection, interferon beta-1a, 1 mcg for intramuscular use
- Q3031 — Collagen skin test
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q3028
- Watch Q3028 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q3028
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.